Verona Pharma plc ADR buy BiotechBee
Start price
24.06.23
/
70%
€19.10
Target price
31.12.25
€40.00
Performance (%)
26.70%
Price
02.09.24
€24.80
Summary
This prediction is currently active. The BUY prediction by BiotechBee currently has a performance of 26.70%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Verona Pharma plc ADR | - | - | - |
iShares Core DAX® | 1.663% | 6.945% | 18.807% |
iShares Nasdaq 100 | 1.261% | 4.883% | 23.667% |
iShares Nikkei 225® | 0.654% | 10.007% | 15.047% |
iShares S&P 500 | 1.403% | 4.350% | 23.305% |
According to BiotechBee what are the pros and cons of Verona Pharma plc ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Verona Pharma Plc diskutieren
Buy mit Kursziel 40,0
Stopped prediction by BiotechBee for Verona Pharma plc ADR
Verona Pharma plc ADR
Start price
Target price
Perf. (%)
€10.30
07.09.22
07.09.22
€18.00
31.12.25
31.12.25
77.67%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year